Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2023
18/4 12:26
Company Announcement Net sales of DARZALEX ® in the first quarter of 202 3 totaled USD 2,264 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN, Denmark; April 18 , 2023 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales...